首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1621892

蛋白酶 K 市場機會、成長動力、產業趨勢分析及 2024 年至 2032 年預測

Proteinase K Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: 2024年10月25日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球蛋白酶 K 市場規模約為 13 億美元，預計 2024 年至 2032 年複合年成長率為 7.5%。慢性病和傳染病是主要促進因素，因為蛋白酶 K 在與這些疾病相關的分子診斷和研究中發揮關鍵作用。導致慢性疾病增加的因素包括人口老化、久坐的生活方式和不良的飲食習慣，進而導致心血管疾病、糖尿病和癌症等疾病。同時，城市化、全球旅行和抗菌素抗藥性的增加推動了傳染病的傳播。

從形式來看，粉末細分市場佔據主導地位，2023 年銷售額達 7.357 億美元。這種穩定性對於實驗室應用至關重要，因為酵素必須在不冷藏的情況下長時間保持活性。此外，粉末製劑通常具有較低的生產和運輸成本，這使得它們對實驗室來說更加經濟，尤其是涉及大規模應用的實驗室。根據治療領域，蛋白酶K市場分為傳染病、腫瘤學、糖尿病、心臟病學和其他治療領域。

預計到 2032 年，傳染病領域將達到 7.953 億美元。蛋白酶 K 在從病原體中分離和純化核酸方面發揮著重要作用，這對於分子診斷至關重要。這大大增加了對利用蛋白酶KUS 的診斷工具的需求，在北美蛋白酶K 市場佔據主導地位，2023 年收入最高為4.562 億美元。的高消費量。此外，傳染病帶來的持續挑戰提高了對利用蛋白酶 K 進行快速測試和研究能力的需求，從而推動了對核酸提取中涉及的酶的需求。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	13億美元
預測值	25億美元
複合年成長率	7.5%

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病和傳染病的盛行率不斷上升
  - 生物技術的進步
  - 技術進步
  - 政府對研究的投資
- 產業陷阱與挑戰
  - 酵素的成本高
成長潛力分析
監管環境
技術景觀
未來市場趨勢
差距分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按形式，2021 - 2032

主要趨勢
粉末
液體

第 6 章：市場估計與預測：按治療領域，2021 - 2032 年

主要趨勢
傳染病
腫瘤學
糖尿病
心臟病學
其他治療領域

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
基因組 DNA 和 RNA 的分離與純化
原位雜合技術
粒線體分離
其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
生技公司
合約研究組織
診斷實驗室
其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第 10 章：公司簡介

Abcam
Agilent Technologies
Bioline (Meridian Biosciences)
BIORON
F. Hoffmann-La Roche
Merck
Minerva Biolabs
MP BIOMEDICALS.
New England Biolabs
Norgen Biotek
Promega Corporation
QIAGEN
Sisco Research Laboratories
Takara Bio
Thermo Fisher Scientific

簡介目錄

Product Code: 11996

The Global Proteinase K Market size was worth around USD 1.3 billion in 2023 and is estimated to grow at 7.5% CAGR from 2024 to 2032. The increasing prevalence of chronic and infectious diseases, along with advancements in biotechnology, is driving market growth. Chronic and infectious diseases are major drivers, as proteinase K plays a critical role in molecular diagnostics and research related to these conditions. Contributing factors to the rise in chronic diseases include an aging population, sedentary lifestyles, and poor dietary habits, leading to conditions such as cardiovascular diseases, diabetes, and cancer. Meanwhile, the spread of infectious diseases is driven by urbanization, global travel, and the rise of antimicrobial resistance.

Based on form, the powder segment dominated the market and accounted for USD 735.7 million in 2023. Powdered proteinase K is more stable than its liquid counterpart, offering a longer shelf life and easier storage conditions. This stability is essential for laboratory applications where enzymes must retain activity over extended periods without refrigeration. Additionally, powdered formulations typically have lower production and shipping costs, making them more economical for laboratories, especially those involved in large-scale applications. Based on therapeutic areas, the proteinase K market is segmented into infectious diseases, oncology, diabetes, cardiology, and other therapeutic areas.

The infectious diseases segment is anticipated to reach USD 795.3 million by 2032. The increasing prevalence of infectious diseases worldwide drives the demand for rapid and accurate diagnostic tests. Proteinase K plays an essential role in the isolation and purification of nucleic acids from pathogens, which is crucial for molecular diagnostics. This significantly bolsters the demand for diagnostic tools that utilize proteinase K. U.S. dominated the North American proteinase K market with the largest revenue of USD 456.2 million in 2023. The U.S. hosts numerous academic and research institutions engaged in genetic and cellular research, leading to high consumption of proteinase K.This indicates that the growth in federal funding for scientific research supports a continuous need for molecular biology tools, including enzymes. Additionally, the ongoing challenges posed by infectious diseases have heightened the need for rapid testing and research capabilities that utilize proteinase K, thereby driving the demand for enzymes involved in nucleic acid extraction.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$1.3 Billion
Forecast Value	$2.5 Billion
CAGR	7.5%

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic and infectious diseases
  - 3.2.1.2 Advancements in biotechnology
  - 3.2.1.3 Technological progress
  - 3.2.1.4 Government investment in research
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of enzymes
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Form, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Powder
5.3 Liquid

Chapter 6 Market Estimates and Forecast, By Therapeutic Area, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Infectious diseases
6.3 Oncology
6.4 Diabetes
6.5 Cardiology
6.6 Other therapeutic areas

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Isolation and purification of genomic DNA & RNA
7.3 In situ hybridization
7.4 Mitochondria isolation
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Biotechnology companies
8.3 Contract research organizations
8.4 Diagnostic laboratories
8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE